Miriam Longo

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

Dario Giugliano, Miriam Longo, Simona Signoriello et al. · Cardiovascular Diabetology · 2022 · 139 citations · Full text

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

Dario Giugliano, Miriam Longo, Paola Caruso et al. · Diabetes Care · 2021 · 65 citations · Full text

Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?

Paola Caruso, Miriam Longo, Katherine Esposito et al. · Diabetes Research and Clinical Practice · 2020 · 52 citations · Full text

Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center

Paola Caruso, Maria Ida Maiorino, Margherita Macera et al. · Diabetes Research and Clinical Practice · 2021 · 51 citations · Full text

Antibiotics, Diabetes, Healthcare-associated Infection +8

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy

Miriam Longo, Paola Caruso, Michela Petrizzo et al. · Diabetes Research and Clinical Practice · 2020 · 49 citations · Full text

Type 1, Diabetes Management, Health Policy +11